Preoperative natriuretic peptides provide additional value for cardiac risk stratification in adults undergoing noncardiac surgery, leading to their recommendation in recent perioperative guidelines.
Does preoperative natriuretic peptide testing improve cardiac risk stratification in adults undergoing noncardiac surgery?
Preoperative natriuretic peptides are recommended by recent guidelines to provide additional value for cardiac risk stratification in at-risk adults undergoing noncardiac surgery.
Cardiac risk evaluation is a central component of most preoperative evaluation of adults undergoing noncardiac surgery. Many tools are available for preoperative cardiac assessment including cardiac risk scores, electrocardiogram, cardiac imaging, and cardiac stress tests. Biomarkers, and more specifically natriuretic peptides, have also been found to provide additional value for preoperative cardiac risk stratification and their routine use in at-risk patients have been recommended in recent perioperative guidelines.
Duceppe et al. (Mon,) conducted a review in Preoperative cardiac risk evaluation in noncardiac surgery. Natriuretic peptides was evaluated. Preoperative natriuretic peptides provide additional value for cardiac risk stratification in adults undergoing noncardiac surgery, leading to their recommendation in recent perioperative guidelines.